Inicio › Cáncer de estómago › California › Los Angeles
Ensayos clínicos de Cáncer de estómago en Los Angeles, CA
22 estudios para Cáncer de estómago buscan participantes en centros de Los Angeles y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- University of California - Los Angeles, Los Angeles
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
ReclutandoFase 2/3
- USC/Norris Comprehensive Cancer Center, Los Angeles
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
ReclutandoFase 3
- UCLA Health, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
ReclutandoFase 1/2
- University of Southern California, Los Angeles
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
ReclutandoFase 2
- Research Site, Los Angeles
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
ReclutandoFase 3
- UCLA, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ReclutandoFase 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutandoFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
ReclutandoFase 1
- ULCA, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- The Angeles Clinic and Research Institute, Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
ReclutandoFase 1/2
- California Research Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
ReclutandoFase 1
- USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
ReclutandoFase 1
- Start Lacn, Los Angeles
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
ReclutandoFase 2
- Research Site, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Reclutando
- Oncology Institute for Hope and Innovation, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Reclutando
- Cedars-Sinai Medical Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
ReclutandoFase 1/2
- University of Southern California, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
ReclutandoFase 1/2
- Cedars Sinai Medical Center, Los Angeles
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
ReclutandoFase 4
- Cedars-Sinai Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
ReclutandoFase 1
- University of Southern California, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
ReclutandoFase 2
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Más información sobre Cáncer de estómago en MedlinePlus
Ensayos de Cáncer de estómago en otras ciudades
- Houston, TX42 estudios
- Boston, MA32 estudios
- New York City, NY31 estudios
- Nashville, TN28 estudios
- Baldwin Park, CA22 estudios
- Arlington, VA20 estudios
- Dallas, TX19 estudios
- San Antonio, TX19 estudios
- Grand Rapids, MI18 estudios
- St. Louis, MO18 estudios
- Chicago, IL16 estudios
- Washington, DC16 estudios
Otros estudios en Los Angeles
- Cáncer de pulmón de células no pequeñas87 estudios
- Cáncer (todos los tipos)74 estudios
- Cáncer de seno73 estudios
- Cáncer de próstata61 estudios
- Cáncer del colon y del recto59 estudios
- Cáncer metastásico57 estudios
- Cáncer de ovario50 estudios
- Cáncer de pulmón45 estudios
- Carcinoma de células escamosas de cabeza y cuello42 estudios
- Cáncer de páncreas35 estudios
- Cáncer de endometrio34 estudios
- Melanoma34 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.